A New Jersey federal judge on Tuesday sentenced the former CEO of a now-defunct medical billing company to five years in prison, the statutory maximum penalty, for his role in a $212.5 million scheme to inflate the value of his company to defraud investors.
Read the full intelligence on AlphaMaven
Subscribe to unlock the AI-extracted Key Takeaways, the News Summary that synthesizes this story with related coverage, and the full alternative-investment intelligence platform — $99/mo, no contract, cancel anytime.